Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
Conditions: Nipah Virus Infection Interventions: Biological: PHV02; Biological: Lactated Ringer ' s Sponsors: Public Health Vaccines LLC; Coalition for Epidemic Preparedness Innovations Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Epidemics | Epidemiology | International Medicine & Public Health | Nipah Virus | Research | Study | Vaccines